Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
61.42M | 56.00M | 54.05M | 53.58M | 46.28M | 60.01M | Gross Profit |
17.14M | 16.53M | 16.47M | 17.92M | 13.19M | 18.67M | EBIT |
9.12M | 8.38M | 9.95M | 11.41M | 7.50M | 10.74M | EBITDA |
10.93M | 9.89M | 11.09M | 12.80M | 8.65M | 12.29M | Net Income Common Stockholders |
7.31M | 7.47M | 10.73M | 8.46M | 4.86M | 9.55M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
70.04M | 77.21M | 105.44M | 110.36M | 116.54M | 122.36M | Total Assets |
124.22M | 132.31M | 159.33M | 160.89M | 163.51M | 171.79M | Total Debt |
367.00K | 135.00K | 182.00K | 227.00K | 119.00K | 420.00K | Net Debt |
-12.39M | -6.43M | -105.26M | -110.13M | -116.42M | -121.94M | Total Liabilities |
16.86M | 19.39M | 43.40M | 25.25M | 27.57M | 30.11M | Stockholders Equity |
107.36M | 112.91M | 115.93M | 135.63M | 135.94M | 141.68M |
Cash Flow | Free Cash Flow | ||||
8.62M | 3.76M | 5.44M | 3.83M | 5.52M | -1.63M | Operating Cash Flow |
9.04M | 4.41M | 6.49M | 8.20M | 13.01M | 5.22M | Investing Cash Flow |
13.84M | 31.39M | -7.02M | -29.56M | 32.96M | -42.51M | Financing Cash Flow |
-14.30M | -33.47M | -8.05M | -7.43M | -9.79M | -28.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $277.56M | 48.03 | 5.35% | 3.59% | 15.45% | -22.33% | |
73 Outperform | $11.75B | 47.75 | 8.51% | ― | 4.62% | 21.58% | |
70 Outperform | $4.27B | 14.27 | 6.42% | 2.55% | -10.52% | -42.40% | |
66 Neutral | $11.55B | 37.32 | 8.65% | 0.52% | -3.83% | -1.93% | |
65 Neutral | $1.89B | 11.37 | -1.45% | 0.72% | -3.82% | -126.04% | |
64 Neutral | $4.46B | 11.94 | 5.17% | 249.36% | 4.00% | -12.35% | |
56 Neutral | $5.88B | 6.84 | -26.94% | 2.72% | -5.98% | -183.27% |